GPhC's FtP performance 'still falling short'
The General Pharmaceutical Council is still failing to hit its performance standards when it comes to dealing with fitness to practice concerns, according to the regulator's performance monitoring report 2020-21, being presented at the council meeting on June 10.
Performance for January to March 2021 was “mixed and continues to fall short of our normal operating standards”, the GPhC said. “There have been improvements in some areas, including sustained improvements in the numbers of concerns triaged within five days. However, there has also been a decline in the timeliness of interim orders (IOs) being imposed where there was information suggesting a serious risk, albeit this involved a very small number of cases.”
The number of concerns triaged within five working days increased to 58 per cent, with just over 70 per cent triaged within five days in March 2021. This was achieved despite an increase in the number of referrals from 762 in Q3 to 860 in Q4, which represents the highest number of referrals during 2020-21. The regulator said it is confident improvements will continue into the next quarter.
Overall, 13 per cent (120) of all concerns triaged were referred for an investigation (stream 2). This was a decrease in terms of percentage on Q3 (20 per cent), although the actual number of cases proceeding for investigation wasn’t significantly lower. It included a large number of cases as a result of enforcement action taken by the inspectorate.
For the remainder of the concerns (509), 45 per cent (442 – an increase from 364 in Q3) were closed either with no further action or with signposting/guidance/health packs, 40.6 per cent (378) were passed to the inspectorate as intelligence and 1.2 per cent (11) were awaiting closure approval or additional information.
Although the number of concerns closed at triage has increased significantly, as a percentage of total cases it has remained relatively stable.
Only two cases went to the fitness to practise committee, one of which was delayed. The GPhC says it “still working hard to progress and conclude older cases, many of which are complex and have involved third party investigations which have added to delays”.
The number of cases on hold over 12 months has remained stable and progress has been made in reducing the number of cases over 12 months at the FtP committee stage.
GPhC Fitness to practise quarterly performance 2020-21
|Performance measure||Performance standard||Q4||Red/Amber/Green||Q3||Q2||Q1|
|Number of concerns triaged within 5 working days||90%||58.0% (540/931)||RED||45.4% (338/744)||28.0% (220/785)||13.7% (94/687)|
|Number of stream 2 cases closed or referred within 44 weeks (10 months)||75%||53.5% (38/71)||RED||59.7% (37/62)||51.8% (43/83)||45.8% (27/59)|
|Number of cases closed or referred at IC which reach IC within 52 weeks (12 months)||70%||25% (3/12)||RED||20% (3/15)||25% (2/8)||25% (2/8)|
|Number of Fitness to Practise committee cases closed within 104 weeks (24 months)||85%||22.2% (2/9)||RED||15.4% (2/13)||45.5% (5/11)||0% (0/2)|
|Median time (weeks) from receipt of information suggesting an immediate risk to interim order (IO) being imposed||3 weeks||4.8 wks (2 IOs)||RED||2.6 wks (5 IOs)||5.1 wks (2 IOs)||2.9 wks (3 IOs)|
Common feeding feeding issues, including coloc, reflux and regurgitation, and some of the ways they can be managed
This module busts the myths surrounding diarrhoea treatments and explores the products available OTC so you can recommend the right treatment.
Record my learning outcomes
Inspiring stories related to health, fitness and the pursuit of wellbeing
More like this
LloydsPharmacy provides lateral flow tests in Scotland and Wales
LloydsPharmacy said the tests can be taken at home and are being provided in 191 stores in Scotland and 81 in Wales.
1 Min Article
PSNC reaches deal with government on pharmacies' Covid costs
But the Treasury insists that pharmacies start paying back the £370m advance payments in six monthly instalments starting from October
2 Min Article
OTC Omeprazole tablets 20mg: an opportunity for pharmacy
This module highlights a new opportunity to treat heartburn and reflux in the pharmacy with Omeprazole 20mg, which is newly available for customers to purchase OTC.
8 Min Module
Helping customers treat & care for their scalp
Understanding the causes and symptoms of some common scalp conditions will help you to make a real difference to your customers’ lives. Complete this module to discover self-care and product advice to help ease symptoms and maintain scalp health.
37 Min Module
Let's talk tech: Using technology to drive your business
This training offers insights into making the most of technology and the commercial opportunities this can offer your business.
8 Min Module